What You Should Know: - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution. - Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More
NIH
COVID-19 Health Systems Impact: What Will Stop The Cash Hemorrhage?
The material cost of COVID-19 has been at the center of public discourse since the early days of the pandemic. In 2020, growth in federal government spending on healthcare increased 36 percent, compared to the 5.9 percent bump in 2019. While the distribution of vaccines has allowed for a version of pre-pandemic life to resume, hospitals are still not recovered from the high rates of hospitalizations that occurred in March 2020, and the indirect costs of the pandemic continue to loom over the
Read More
RNSA22: Flywheel Builds Data Platform for Unbiased Breast Imaging AI
What You Should Know: - Today, at RSNA, Flywheel, a leading data management platform for biomedical research and collaboration announces the creation of a federated data platform for the development of unbiased breast imaging AI. - Funded in part by the NIH, the federated network will support breast imaging AI research and collaboration—on a scale not previously possible. Leveraging Flywheel Discovery & Exchange Two Flywheel technologies underpin the project. Flywheel
Read More
Geneial Receives $2.3M NIH Grant for Decentralized Biomedical Data Platform
What You Should Know: - Digital health company Geneial announces a $2.3M grant from the National Human Genome Research Institute to fund the development of their secure, decentralized platform. - Geneial will use $2.3M NIH award to build private, decentralized data platform facilitating research of genetic diseases. Geneial's platform will connect researchers of rare genetic diseases with relevant data while preserving patient privacy. Geneial's platform aims to help researchers leverage
Read More
Eko Lands $2.7M NIH Grant to Train Pulmonary Hypertension AI
What You Should Know: - Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7M Small Business Innovation Research (SBIR) Direct Phase II grant by the National Institutes of Health’s (NIH) Department of Health and Human Services (HHS). - The grant will fund the development of a machine learning algorithm that detects and stratifies pulmonary hypertension (PH) using phonocardiogram (PCG) and
Read More
Outdated Pain Models & The Rise of New Science on Chronic Pain
More than 50 million adults in the United States – more than 20% – suffer from chronic pain, and more than 19.6 million adults have pain that interferes with their lives more days than not. The estimated cost of chronic pain is $635 billion – more than heart disease and cancer combined – due to the number of days missed from work, treatment costs, and other factors. Chronic pain is the leading cause of disability, but the current pain treatment system isn’t working. This is because it hasn’t
Read More
PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease
What You Should Know: - Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study. - The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms. Challenges Diagnosing Parkinson’s
Read More
Salignostics Raises $8M for Rapid Saliva-Based Test Kits That Detect Pregnancy, COVID-19, Cardiac Risk, and Malaria
What You Should Know: - Israeli startup Salignostics, the developer and provider of rapid saliva-based tests for early pregnancy detection, as well as COVID-19, cardiac risk, malaria, and other diseases, has closed an $8 million Series A funding round from private investors headed by angel investor Avigdor Orlinsky. - The company has raised $16M to date to support development, commercialization, and marketing efforts for the tests in Israel and overseas. It will also support the launch of
Read More
Selux Diagnostics Raises $50M for Next-Generation Phenotyping Platform
What You Should Know: - Selux Diagnostics, Inc., a personalized diagnostics company to combat superbug infections and fight antibiotic resistance raises $50M in Series C financing led by RA Capital Management, with participation from Sands Capital, Schooner Capital and Northpond Ventures. - The funding will support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform. Precision diagnostics for
Read More
Crisis in the U.S. Healthcare Workforce: Why It’s Time to introduce AI
One of the many acute challenges during the pandemic has been the departure of approximately 18% of the U.S. healthcare workforce,4 resulting in staffing shortages in hospitals. This has impacted the well-being of the remaining healthcare practitioners 5 as well as their patients – many of whom are deferring care that is vital to disease management and overall maintenance of health,6,7 or who do not have access to timely emergency care.1 Though such challenges may be perceived as insurmountable
Read More